SN:006/25
| 
|
Concerns regarding Achromobacter
contamination of antiseptic products
| 20 March 2025 |
SI:004/25
|
|
Clinician Alert - Measles in NSW
| 17 March 2025
|
| SN:004/25 |
|
Updated: Risk of retained intubating stylet fragments in neonates | 11 March 2025 |
SI:003/25
| | Updated: Prevention of infection transmission to and from health care workers
| 11 March 2025 |
SA:001/25
|  |
Managing the shortage of neonatal and paediatric endotracheal tubes | 7 March 2025 |
| SI:002/25 |
|
Risk of harm from inappropriate placement of pulse oximeter probes | 3 March 2025 |
| SN:003/25 |
|
Updated: Disruption to supply – Gentamicin (Pfizer®) 80 mg/2 mL (as sulfate) injection BP ampoule | 6 February 2025 |
| SN:002/25 |
|
Updated: Disruption to supply of multiple intravenous fluid bags | 29 January 2025 |
| SA:001/25 |
|
Suspected botulism following cosmetic injections | 24 January 2025 |
| SN:001/25 |
|
Updated: Contamination of heater cooler units with
Mycobacteria chimaera | 21 January 2025 |
| SN:036/24 |
|
Updated: Disruption to supply: Heparin sodium (Pfizer®) injection ampoules (multiple strengths) | 16 December 2024 |
| SN:035/24 |
|
Discontinuation of multiple insulin products | 16 December 2024 |
| SI:009/24 |
|
Risk for Japanese Encephalitis Virus (JEV) following detection in mosquitoes | 12 December 2024 |
| SN:033/24 |
|
Updated: Prothrombin complex concentrate transition to Beriplex®: clinical considerations | 11 December 2024 |
| SN:032/24 |
|
Changes to cryoprecipitate doses: Implications for Massive Haemorrhage Protocols | 10 December 2024 |
| SI:008/24 |
|
Safe prescribing and administration of palliative care syringe drivers | 25 November 2024 |
| SN:031/24 |
|
Maternity Telephone Consultations | 20 November 2024 |
| SI:007/24 |
|
Potential risk of neurodevelopmental disorders in children of fathers treated with valproate | 11 November 2024 |
| SN:030/24 |
|
Disruption to supply of adrenaline (epinephrine) 1:10,000 (1 mg/10 mL) pre-filled syringes and safety considerations | 1 November 2024 |
| SN:029/24 |
|
Updated: Assessment and care of early labour; opioid and non-opioid analgesia. | 24 October 2024 |
| SN:028/24 |
|
Updated: Disruption to supply – Azithromycin (Zithromax) 200 mg/5 mL powder for oral suspension | 15 October 2024 |
| SI:006/24 |
|
Safe management of look-alike, sound-alike medicines in NSW Health facilities | 14 October 2024 |
| SN:023/24 |
|
Updated: Cases of dependence and overdose linked to nitazenes (strong opioids) in refillable vape liquids | 26 August 2024 |
| SN:022/24 |
|
Updated: Mpox is spreading across NSW | 8 August 2024 |
| SN:018/24 |
|
Risk of severe allergic reactions from products containing Andrographis paniculata | 5 July 2024 |
| SN:015/24 |
|
Unexpected toxicity associated with Uncle Frog’s Mushroom Gummies | 26 June 2024 |
| SI:005/24 |
|
Avian Influenza risk summary | 21 June 2024 |
| SN:012/24 |
|
Middle Eastern Respiratory Syndrome | 20 June 2024 |
| SI:004/24 |
|
Updated: Minimising choking risk inmental health consumers | 13 June 2024 |
| SN:011/24 |
|
Risk of toxicity from ‘colic preparations’ containing belladonna | 7 June 2024 |
| SA:009/24 |
|
Medicine recall: Phytomenadione (Konakion MM) 2 mg/0.2 mL injection | 4 June 2024 |
| SN:009/24 |
|
Nitazenes causing severe opioid overdoses in NSW | 30 May 2024 |
| SN:007/24 |
|
Updated: Changes to supply of morphine oral liquid in Australia | 21 May 2024 |
| SI:003/24 |
|
Counterfeit diazepam found in NSW | 16 May 2024 |
| SN:006/24 |
|
Updated: Supply disruption: Rapid Fetal Fibronectin (fFN) 10Q cassettes | 8 May 2024 |
| SA:005/24 |
|
Clinician Alert – Rabies Risk for Timor-Leste | 28 March 2024 |
| SN:002/24 |
|
Use of Trilogy Evo, Trilogy Evo 02 and Trilogy EV300 devices while in CPAP and PSV mode | 18 March 2024 |
| SA:003/24 |
|
Updated: Clinician Alert - Legionella pneumophilia | 23 February 2024 |
| SI:001/24 |
|
Fluid therapy and medicine dosing in adult patients who have a low body weight | 06 February 2024 |
| SN:044/23 |
|
Updated: Safe use of magnesium sulfate heptahydrate in maternity services | 20 December 2023 |
| SN:042/23 |
|
Updated: Transvaginal mesh implants for Pelvic Organ (Vaginal) Prolapse | 18 December 2023 |
| SN:041/23 |
|
Updated: Possible contamination of multiple sodium chloride products – Quarantine and recall actions | 15 December 2023 |
| SI:016/23 |
|
Updated: Optimisation of elastomeric infusion devices | 14 December 2023 |
| SI:014/23 |
|
Updated: Potential increased risk of perinatal mortality associated with home fetal heart rate monitors (fetal dopplers) and baby movement Apps | 30 November 2023 |
| SN:035/23 |
|
Updated - Provision of written leave information for consumers on leave from mental health inpatient units | 24 November 2023 |
| SN:034/23 |
|
Disruption to supply – Olanzapine long-acting injection (Zyprexa Relprevv) | 24 November 2023 |
| SI:012/23 |
|
Updated: Electronic Fetal Monitoring (EFM) during water immersion | 17 November 2023 |
| SI:011/23 |
|
Updated: Composition of counterfeit alprazolam in NSW | 3 November 2023 |
| SN:030/23 |
|
Updated: Set up of neonatal resuscitaires | 26 October 2023 |
| SA:008/23 |
|
Updated: Clinician Alert - Invasive group A streptococcal disease | 15 September 2023 |
| SA:007/23 |
|
Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pumps (IABP) | 12 September 2023 |
| SN:025/23 |
|
Updated - Medication management in patients with Parkinson Disease | 7 September 2023 |
| SN:023/23 |
|
Disruption to supply – Lidocaine (lignocaine) 1% (50 mg/5 mL) and 2% (100 mg/5 mL) solution for injection (Pfizer and Baxter) | 23 August 2023 |
| SN:020/23 |
|
Disruption to supply - Glucagon 1 mg (GlucaGen® Hypokit®) | 10 August 2023 |
| SN:019/23 |
|
Cosmetics potentially containing metal in Magnetic Resonance Imaging | 7 August 2023 |
| SN:017/23 |
|
Intravenous and subcutaneous Immunoglobulins (IVIg and SCIg): Potential for error: look-alike / sound-alike | 27 July 2023 |
| SN:015/23 |
|
Getinge Intra-Aortic Balloon Pump catheter insertion | 28 June 2023 |
| SN:013/23 |
|
Risk of burn injury from degraded insulated laparoscopic instruments | 25 May 2023 |
| SI:008/23 |
|
Updated: Reporting Adverse Events Following Immunisation | 23 May 2023 |
| SN:012/23 |
|
Disruption to supply: Potassium chloride (Pfizer) concentrate 10 mmol (750 mg) in 10 mL injection ampoule | 18 May 2023 |
| SN:011/23 |
|
Discontinuation of thiopental sodium (Pentothal®) 500 mg vial for injection | 9 May 2023 |
| SN:010/23 |
|
Updated: Illicit cocaine containing high levels of lidocaine (lignocaine) | 4 May 2023 |
| SN:007/23 |
|
Disruption to supply: Suxamethonium chloride (Juno) 100 mg/2 mL injection | 4 April 2023 |
| SN:006/23 |
|
Updated: Use of Prone Restraint and Parenteral Medication in Healthcare Settings | 30 March 2023 |
| SI:006/23 |
|
Intravenous iron preparations and potential for skin staining | 29 March 2023 |
| SI:005/23 |
|
Updated: Paediatric stationary oxygen concentrator set-up - Absence of low flow alarm for flow rates less than 2 litres per minute | 28 March 2023 |
| SN:004/23 |
|
Clinician Alert – Foodborne Botulism | 22 February 2023 |
| SA:002/23 |
|
Updated: Defect alert: Computerised Ambulatory Delivery Device (CADD) Infusion pump disposables | 12 January 2023 |
| SI:013/22 |
|
Increased incidence of invasive meningococcal disease | 19 December 2022 |
| SN:023/22 |
|
Newly registered Australian product: Risks associated with lorazepam 4 mg/1 mL solution for injection | 1 December 2022 |
| SN:021/22 |
|
Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) - Updated | 11 November 2022 |
| SN:007/22 |
|
Avoiding thrombophlebitis with intravenous amiodarone - Updated | 18 July 2022 |
| SI:001/22 |
|
Recognition and prompt treatment of clozapine-induced constipation | 7 February 2022 |
| SI:009/21 |
|
Recirculating air filtration device use in NSW hospitals | 26 November 2021 |
| SI:004/21 |
|
Povidone-Iodine Solution Use in NSW Hospitals | 19 August 2021 |
| SN:016/21 |
|
Identification and monitoring of Post-Injection Syndrome Olanzapine Pamoate Long Acting Injection (updated) | 9 August 2021 |
| SI:007/21 |
|
Safe use of medications with multiple concentrations in Electronic Medication Management (EMM) systems | 9 July 2021 |
| SN:002/21 |
|
Variability in oxygen delivery with bag valve masks | 15 February 2021 |
| SI:001/21 |
|
Minimising the risks of serious harm while switching antipsychotics | 20 January 2021 |
| SN:001/21 |
|
Discontinuation of nifedipine immediate release products (update) | 18 January 2021 |
| SI:003/20 |
|
The risk of toxicity from topical anaesthetic products | 22 May 2020 |
| SN:001/20 |
|
Safe provision of sedating medicines on discharge from NSW Health facilities | 18 February 2020 |
| SN:013/19 |
|
Incompatibility between oxygen cylinders with inbuilt regulators with Air/Oxygen Blenders | 26 September 2019 |
| SI:003/18 |
|
Candida auris infection considerations for the transfer or repatriation of an overseas patient to a NSW hospital | 7 September 2018 |
| SN:008/18 |
|
Return of Patients’ Own Medications | 25 July 2018 |
| SI:001/14 |
|
Correct Usage of Fume/Vapour Soaking Stations | 24 January 2014 |
| SN:001/14 |
|
Use of Impregnated Chemical Disinfectant Wipe Systems for Reusable Medical Devices | 24 January 2014 |
| SN:022/09 |
|
Safe use of Midazolam | 18 December 2009 |